Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

HPLC/UV/MS method application for the separation of obeticholic acid and its related compounds in development process and quality control.

Douša M, Slavíková M, Kubelka T, Černý J, Gibala P, Zezula J.

J Pharm Biomed Anal. 2018 Feb 5;149:214-224. doi: 10.1016/j.jpba.2017.11.018. Epub 2017 Nov 4.

PMID:
29126083
2.

A novel approach for HPLC determination of 2-cynaoacetamide using derivatization procedure with 2-hydroxyacetophenone as a new useful derivatization reagent.

Douša M, Břicháč J, Tkadlecová M, Man S, Zezula J, Hájíček J, Pekárek T.

J Pharm Biomed Anal. 2016 Sep 5;128:391-397. doi: 10.1016/j.jpba.2016.06.016. Epub 2016 Jun 10.

PMID:
27344628
3.

A two-state model for the diffusion of the A2A adenosine receptor in hippocampal neurons: agonist-induced switch to slow mobility is modified by synapse-associated protein 102 (SAP102).

Thurner P, Gsandtner I, Kudlacek O, Choquet D, Nanoff C, Freissmuth M, Zezula J.

J Biol Chem. 2014 Mar 28;289(13):9263-74. doi: 10.1074/jbc.M113.505685. Epub 2014 Feb 7.

4.

A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog.

Hagelkruys A, Lagger S, Krahmer J, Leopoldi A, Artaker M, Pusch O, Zezula J, Weissmann S, Xie Y, Schöfer C, Schlederer M, Brosch G, Matthias P, Selfridge J, Lassmann H, Knoblich JA, Seiser C.

Development. 2014 Feb;141(3):604-616. doi: 10.1242/dev.100487.

5.

Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.

Thurner P, Stary-Weinzinger A, Gafar H, Gawali VS, Kudlacek O, Zezula J, Hilber K, Boehm S, Sandtner W, Koenig X.

J Pharmacol Exp Ther. 2014 Feb;348(2):346-58. doi: 10.1124/jpet.113.209643. Epub 2013 Dec 4.

PMID:
24307198
6.

Reengineering the collision coupling and diffusion mode of the A2A-adenosine receptor: palmitoylation in helix 8 relieves confinement.

Keuerleber S, Thurner P, Gruber CW, Zezula J, Freissmuth M.

J Biol Chem. 2012 Dec 7;287(50):42104-18. doi: 10.1074/jbc.M112.393579. Epub 2012 Oct 15.

7.

Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans.

Zezula J, Singer L, Przybył AK, Hashimoto A, Dersch CM, Rothman RB, Deschamps J, Lee YS, Jacobson AE, Rice KC.

Org Biomol Chem. 2008 Aug 21;6(16):2868-83. doi: 10.1039/b803433h. Epub 2008 Jun 13.

8.

Profound inhibition of antigen-specific T-cell effector functions by dasatinib.

Weichsel R, Dix C, Wooldridge L, Clement M, Fenton-May A, Sewell AK, Zezula J, Greiner E, Gostick E, Price DA, Einsele H, Seggewiss R.

Clin Cancer Res. 2008 Apr 15;14(8):2484-91. doi: 10.1158/1078-0432.CCR-07-4393.

9.

Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development.

Galabova-Kovacs G, Catalanotti F, Matzen D, Reyes GX, Zezula J, Herbst R, Silva A, Walter I, Baccarini M.

J Cell Biol. 2008 Mar 10;180(5):947-55. doi: 10.1083/jcb.200709069.

10.

The A(2A)-adenosine receptor: a GPCR with unique features?

Zezula J, Freissmuth M.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S184-90. doi: 10.1038/sj.bjp.0707674. Epub 2008 Feb 4. Review.

11.

Restricted collision coupling of the A2A receptor revisited: evidence for physical separation of two signaling cascades.

Charalambous C, Gsandtner I, Keuerleber S, Milan-Lobo L, Kudlacek O, Freissmuth M, Zezula J.

J Biol Chem. 2008 Apr 4;283(14):9276-88. doi: 10.1074/jbc.M706275200. Epub 2008 Jan 24.

13.

Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.

Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O.

FASEB J. 2001 Jul;15(9):1607-9. No abstract available.

PMID:
11427501
14.

p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal.

Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A.

EMBO Rep. 2001 Jan;2(1):27-34.

15.

The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells.

Zezula J, Sexl V, Hutter C, Karel A, Schütz W, Freissmuth M.

J Biol Chem. 1997 Nov 21;272(47):29967-74.

16.

Interaction of allosteric ligands with GABAA receptors containing one, two, or three different subunits.

Zezula J, Slany A, Sieghart W.

Eur J Pharmacol. 1996 Apr 22;301(1-3):207-14.

PMID:
8773466
17.

Allosteric modulation of [3H]flunitrazepam binding to recombinant GABAA receptors.

Slany A, Zezula J, Fuchs K, Sieghart W.

Eur J Pharmacol. 1995 Oct 15;291(2):99-105.

PMID:
8566181
19.

[3H]propyl-6-azido-beta-carboline-3-carboxylate: a new photoaffinity label for the GABAA-benzodiazepine receptor.

Zezula J, Karall S, Dodd RH, Sieghart W.

Eur J Pharmacol. 1995 Jul 25;281(1):93-6.

PMID:
8566124
20.

Endogenous [3H]flunitrazepam binding in human embryonic kidney cell line 293.

Fuchs K, Zezula J, Slany A, Sieghart W.

Eur J Pharmacol. 1995 Mar 15;289(1):87-95.

PMID:
7781715
21.

Cyclosporin A reduces skin collagen content in renal graft recipients.

Lubec B, Stockenhuber X, Weninger M, Zezula J, Lubec G.

Amino Acids. 1993 Feb;5(1):91-7. doi: 10.1007/BF00806195.

PMID:
24190647
22.

Biochemical, immunological, and pharmacological characterization of GABAA-benzodiazepine receptor subtypes.

Sieghart W, Fuchs K, Zezula J, Buchstaller A, Zimprich F, Lassmann H.

Adv Biochem Psychopharmacol. 1992;47:155-62. Review. No abstract available.

PMID:
1324569
23.
24.
25.

Immunohistochemical localization of the alpha 1, alpha 2 and alpha 3 subunit of the GABAA receptor in the rat brain.

Zimprich F, Zezula J, Sieghart W, Lassmann H.

Neurosci Lett. 1991 Jun 10;127(1):125-8.

PMID:
1715535
26.

Benzodiazepine receptor sites in the human brain: autoradiographic mapping.

Zezula J, Cortés R, Probst A, Palacios JM.

Neuroscience. 1988 Jun;25(3):771-95.

PMID:
2841624
27.

[Epidemiologic study of patients with laryngeal carcinoma in the South Moravia Region 1980-1985].

Zezula J.

Cesk Otolaryngol. 1987 Sep;36(5):308-15. Czech. No abstract available.

PMID:
3664712
28.
29.

[Embryonal rhabdomyosarcoma of the nose and paranasal sinuses in an adult male].

Zezula J, Foukal T, Kucera P, Feit J.

Cesk Otolaryngol. 1983 Feb;32(1):49-53. Czech. No abstract available.

PMID:
6839377
30.

[Angioimmunoblastic lymphadenopathy (AIL) in a 70-year-old patient with otorhinolaryngologic manifestations].

Zezula J, Foukal T.

Cesk Otolaryngol. 1982 Aug;31(4):230-4. Czech. No abstract available.

PMID:
7139769
31.

[T and B lymphocytes in laryngeal carcinoma].

Zezula J, Rejtnar A, Sůva P.

Cesk Otolaryngol. 1981 Apr;30(2):70-4. Czech. No abstract available.

PMID:
6972271
32.

[Results of vasodilation therapy in inner ear diseases].

Zezula J, Prívara M, Hoffmannová D.

Cesk Otolaryngol. 1980 Aug;29(4):208-15. Czech. No abstract available.

PMID:
7407999
33.

[Immunoglobulin levels in otorhinolaryngologic tumors].

Zezula J, Vojtísková M.

Cesk Otolaryngol. 1979 Oct;28(5):276-82. Czech. No abstract available.

PMID:
509612
34.

[Radioactive water in reactors; their deactivation and removal].

ZEZULA J.

Prac Lek. 1957 Nov;9(5):431-9 contd. Czech. No abstract available.

PMID:
13542390

Supplemental Content

Loading ...
Support Center